Differences in drug response of the sporogonous cycles of three strains of Plasmodium falciparum in Anopheles stephensi.
D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology*; D000962:Antimalarials / Q000494:pharmacology* / Q000627:therapeutic use; D009033:Culicidae; D004352:Drug Resistance, Microbial; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D006801:Humans; D008288:Malaria / Q000188:drug therapy; D010963:Plasmodium falciparum / Q000187:drug effects*; D011739:Pyrimethamine / Q000494:pharmacology* / Q000627:therapeutic use; D011743:Pyrimidines / Q000494:pharmacology*; D014227:Triazines / Q000494:pharmacology* / Q000627:therapeutic use; D014295:Trimethoprim / Q000494:pharmacology / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000962:Antimalarials; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014227:Triazines; D014295:Trimethoprim; D011739:Pyrimethamine